Excellent in depth interview with our wonderful CEO - well worth a listen. Among many, many topics discussed, she talks about off label expansions which I found very interesting.
CEO and Managing Director Dr Liz Dallimore joins hosts Caroline Duell and WA Life Sciences Innovation Hub Director, Dr Tracey Wilkinson, to discuss the company’s journey from research institute spinout, working with the US FDA, the benefits of conducting clinical trials in Australia, the challenges of raising capital, and why she is passionate about representing the biotech sector on various boards.
https://podcasts.apple.com/au/podca...tment-to-protect/id1453637211?i=1000652697294
AGN Media thread, page-71
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
0.035(4.96%) |
Mkt cap ! $91.53M | |||
| Open | High | Low | Value | Volume |
| 72.5¢ | 74.0¢ | 71.0¢ | $123.3K | 168.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 31174 | 4 |
View Market Depth
| Last trade - 15.56pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
73.5¢ |
Change
0.035 ( 6.52 %) |
||||
| Open | High | Low | Volume | ||
| 71.5¢ | 73.5¢ | 71.0¢ | 43476 | ||
| Last updated 15.49pm 17/06/2024 ? | |||||
| AGN (ASX) Chart |
